SCHEMBL3479694

SCHEMBL3479694

CN1CCN(c2cccc(F)c2)c2cc(-n3ncccc3=O)ccc2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.39
KCNH2 Q12809 1/20 0.39
MAPK14 Q16539 2/20 0.36
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
HPGDS O60760 1/20 0.36
TP53 P04637 1/20 0.35
P2RX7 Q99572 1/20 0.35
HTR2C P28335 4/20 0.34
HTR2B P41595 4/20 0.34
SLC6A2 P23975 2/20 0.34
HTR2A P28223 2/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
SCN9A Q15858 1/20 0.34
PTPN1 P18031 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479708 0.91 HRH3 (0.41) HRH3KCNH2MAPK14TP53P2RX7
SCHEMBL3479422 0.89 KCNH2 (0.43) HRH3KCNH2DRD2DRD3TP53
SCHEMBL3479316 0.84 HRH3 (0.39) HRH3KCNH2P2RX7CA12CA1
SCHEMBL3227525 0.84 HRH3 (0.41) HRH3KCNH2DRD2DRD3SLC6A2
SCHEMBL3479590 0.83 HRH3 (0.40) HRH3KCNH2MAPK14DRD2DRD3
SCHEMBL3217809 0.82 HRH4 (0.40) KCNH2DRD2DRD3HTR2CHTR2B
SCHEMBL3479734 0.80 HRH3 (0.39) HRH3KCNH2DRD2DRD3P2RX7
SCHEMBL3479717 0.80 HRH3 (0.39) HRH3KCNH2P2RX7HTR2CSLC6A2
SCHEMBL3479741 0.80 HRH3 (0.42) HRH3KCNH2DRD3P2RX7SLC6A2
SCHEMBL3222466 0.78 HRH3 (0.39) HRH3KCNH2MAPK14P2RX7SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D HRH3 84/4885KCNH2 537/4885MAPK14 4357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.